{"transactions":[{"id":854168,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Performance Shares","published_at":"2026-03-09T21:04:01.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":10918,"price":128.24,"value":1400124.32,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 31, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 31, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates."}],"balance_after":10918,"derivative":{"expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":10918},"source":{"system":"sec-edgar","filing":"0001110803-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000111080326000072/form4.xml","form_type":"4"}},{"id":854167,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Performance Shares","published_at":"2026-03-09T21:04:01.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":10918,"price":128.24,"value":1400124.32,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates."}],"balance_after":10918,"derivative":{"expiration_date":"2028-12-31","underlying":"Common Stock","underlying_shares":10918},"source":{"system":"sec-edgar","filing":"0001110803-26-000072","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000111080326000072/form4.xml","form_type":"4"}},{"id":854166,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-09T21:04:01.000Z","date":"2026-03-05","kind":"grant","planned":false,"acquired":true,"shares":9358,"price":128.24,"value":1200069.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, subject to awardee's continuing status as a service provider on such dates."}],"balance_after":34264,"source":{"system":"sec-edgar","filing":"0001110803-26-000072","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000111080326000072/form4.xml","form_type":"4"}},{"id":1149642,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-14T20:20:13.000Z","date":"2025-05-12","kind":"purchase","planned":false,"acquired":true,"shares":6100,"price":81.21,"value":495381.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average purchase price representing 6,100 shares purchased ranging from $81.16 to $81.21 per share. Number of shares purchased at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request."}],"balance_after":24906,"source":{"system":"sec-edgar","filing":"0001127602-25-014280","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760225014280/form4.xml","form_type":"4"}},{"id":1218041,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Performance Shares","published_at":"2025-03-07T21:18:49.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":11437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending January 2, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending January 2, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending January 2, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending January 2, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates."}],"balance_after":11437,"derivative":{"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":11437},"source":{"system":"sec-edgar","filing":"0001127602-25-008707","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760225008707/form4.xml","form_type":"4"}},{"id":1218040,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Performance Shares","published_at":"2025-03-07T21:18:49.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":11437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average operating margin for fiscal years 2025-2027 with vesting on January 2, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average operating margin for fiscal years 2025-2027, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average operating margin for fiscal years 2025-2027 with vesting on January 2, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average operating margin for fiscal years 2025-2027, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates."}],"balance_after":11437,"derivative":{"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":11437},"source":{"system":"sec-edgar","filing":"0001127602-25-008707","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760225008707/form4.xml","form_type":"4"}},{"id":1218039,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-07T21:18:49.000Z","date":"2025-03-05","kind":"grant","planned":false,"acquired":true,"shares":9803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2026, February 15, 2027, February 15, 2028, and February 15, 2029, subject to awardee's continuing status as a service provider on such dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In connection with Illumina's spin out of Grail, Inc., which was completed on June 24, 2024, all unvested equity award units were adjusted pursuant to Illumina's Amended and Restated 2015 Stock and Incentive Plan. Mr. Dhingra's unvested RSUs were increased by 177 units as a result of such adjustment."}],"balance_after":18806,"source":{"system":"sec-edgar","filing":"0001127602-25-008707","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760225008707/form4.xml","form_type":"4"}},{"id":1523580,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Performance Shares","published_at":"2024-05-08T22:17:56.000Z","date":"2024-05-06","kind":"grant","planned":false,"acquired":true,"shares":10296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending January 3, 2027. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending January 3, 2027, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending January 3, 2027. The number of shares issued will range from 0% to 200% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending January 3, 2027, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates."}],"balance_after":10296,"derivative":{"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":10296},"source":{"system":"sec-edgar","filing":"0001127602-24-014675","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760224014675/form4.xml","form_type":"4"}},{"id":1523579,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Performance Shares","published_at":"2024-05-08T22:17:56.000Z","date":"2024-05-06","kind":"grant","planned":false,"acquired":true,"shares":10296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average operating margin for fiscal years 2024-2026 with vesting on January 3, 2027 . The number of shares issued will range from 0% to 200% of the amount specified above, based on the Company's actual three-year average operating margin for fiscal years 2024-2026 , relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average operating margin for fiscal years 2024-2026 with vesting on January 3, 2027 . The number of shares issued will range from 0% to 200% of the amount specified above, based on the Company's actual three-year average operating margin for fiscal years 2024-2026 , relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates."}],"balance_after":10296,"derivative":{"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":10296},"source":{"system":"sec-edgar","filing":"0001127602-24-014675","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760224014675/form4.xml","form_type":"4"}},{"id":1523578,"issuer":{"id":3137,"kind":"organization","name":"ILLUMINA, INC.","symbol":"ILMN"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"officer":true,"officer_title":"SVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-08T22:17:56.000Z","date":"2024-05-06","kind":"grant","planned":false,"acquired":true,"shares":8826,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units with 25% of the shares subject to the award vesting on each of the first, second, third and fourth anniversaries of the date of grant, subject to the awardee's continuing to be a service provider on such dates."}],"balance_after":8826,"source":{"system":"sec-edgar","filing":"0001127602-24-014675","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1110803/000112760224014675/form4.xml","form_type":"4"}},{"id":1559220,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-28T00:27:03.000Z","date":"2024-03-26","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":3.75,"value":375000.0,"ownership":{"direct":false,"nature":"By Dhingra Family Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.74 to $3.76 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":354958,"source":{"system":"sec-edgar","filing":"0001599298-24-000046","document":"wk-form4_1711585608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929824000046/wk-form4_1711585608.xml","form_type":"4"}},{"id":1712105,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-13T21:49:19.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":19700,"price":2.17,"value":42749.0,"ownership":{"direct":false,"nature":"By Dhingra Family Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased these shares in a single transaction on the open market."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":254958,"source":{"system":"sec-edgar","filing":"0001599298-23-000101","document":"wk-form4_1702504149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929823000101/wk-form4_1702504149.xml","form_type":"4"}},{"id":1712104,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-13T21:49:19.000Z","date":"2023-12-13","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":2.15,"value":1505.0,"ownership":{"direct":false,"nature":"By Dhingra Family Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased these shares in a single transaction on the open market."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":235258,"source":{"system":"sec-edgar","filing":"0001599298-23-000101","document":"wk-form4_1702504149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929823000101/wk-form4_1702504149.xml","form_type":"4"}},{"id":1962530,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-08T22:24:11.000Z","date":"2023-03-07","kind":"purchase","acquired":true,"shares":196362,"price":1.05,"value":206180.1,"ownership":{"direct":false,"nature":"By Dhingra Family Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":234558,"source":{"system":"sec-edgar","filing":"0001849682-23-000004","document":"wf-form4_167831424008442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000184968223000004/wf-form4_167831424008442.xml","form_type":"4"}},{"id":1962529,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-08T21:58:33.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":24658,"price":0.97,"value":23918.26,"ownership":{"direct":false,"nature":"By Dhingra Family Revocable Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":38196,"source":{"system":"sec-edgar","filing":"0001849682-23-000002","document":"wf-form4a_167831269908577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000184968223000002/wf-form4a_167831269908577.xml","form_type":"4/A","original_submission_date":"2022-08-17"}},{"id":1962528,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-08T21:58:33.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":13027,"price":0.97,"value":12636.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 is being amended to correct the number of shares purchased by the Reporting Person in the Issuer's rights offering. 1,470 shares were inadvertently omitted from the original filing."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to correct the number of shares purchased by the Reporting Person in the Issuer's rights offering. 1,470 shares were inadvertently omitted from the original filing."}],"balance_after":39527,"source":{"system":"sec-edgar","filing":"0001849682-23-000002","document":"wf-form4a_167831269908577.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000184968223000002/wf-form4a_167831269908577.xml","form_type":"4/A","original_submission_date":"2022-08-17"}},{"id":2180664,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-17T20:49:01.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":24658,"price":0.97,"value":23918.26,"ownership":{"direct":false,"nature":"By Dhingra Family Revocable Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":38196,"source":{"system":"sec-edgar","filing":"0001599298-22-000102","document":"wf-form4_166076931714249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929822000102/wf-form4_166076931714249.xml","form_type":"4"}},{"id":2180663,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-17T20:49:01.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":11557,"price":0.97,"value":11210.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering."}],"balance_after":38057,"source":{"system":"sec-edgar","filing":"0001599298-22-000102","document":"wf-form4_166076931714249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000159929822000102/wf-form4_166076931714249.xml","form_type":"4"}},{"id":2246952,"issuer":{"id":3477,"kind":"organization","name":"Summit Therapeutics Inc.","symbol":"SMMT"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-02T21:29:35.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":600000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on May 31, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on May 31, 2023 (the one-year anniversary of the grant date)."}],"balance_after":600000,"derivative":{"exercise_price":1.33,"expiration_date":"2032-05-31","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001849682-22-000003","document":"wf-form4_165420535405545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1599298/000184968222000003/wf-form4_165420535405545.xml","form_type":"4"}},{"id":2316434,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-28T23:31:42.000Z","date":"2022-03-25","kind":"tax_withholding","acquired":false,"shares":1254,"price":37.9,"value":47526.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."}],"balance_after":33146,"source":{"system":"sec-edgar","filing":"0001217234-22-000070","document":"wf-form4_164851028685319.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723422000070/wf-form4_164851028685319.xml","form_type":"4"}},{"id":2411486,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-04T22:48:37.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":34900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4th of the shares subject to the option shall vest on February 2, 2023 and 1/48th of the shares subject to the option shall vest monthly thereafter."}],"balance_after":34900,"derivative":{"exercise_price":41.32,"expiration_date":"2023-02-02","underlying":"Common Stock","underlying_shares":34900},"source":{"system":"sec-edgar","filing":"0001217234-22-000039","document":"wf-form4_164401490341588.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723422000039/wf-form4_164401490341588.xml","form_type":"4"}},{"id":2411485,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-04T22:48:37.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":19900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, 1/4th of which shall vest on February 2, 2023 and 1/4th of which shall vest on each anniversary thereafter."}],"balance_after":34400,"source":{"system":"sec-edgar","filing":"0001217234-22-000039","document":"wf-form4_164401490341588.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723422000039/wf-form4_164401490341588.xml","form_type":"4"}},{"id":2493000,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-29T21:19:28.000Z","date":"2021-11-24","kind":"purchase","acquired":true,"shares":5000,"price":42.3387,"value":211693.5,"ownership":{"direct":false,"nature":"By Dhingra Family Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.91 to $42.72, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001849682-21-000002","document":"wf-form4_163822074936329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000184968221000002/wf-form4_163822074936329.xml","form_type":"4"}},{"id":2771755,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-25T21:56:23.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option shall vest on March 25, 2022 and 1/48th of the shares subject to the option shall vest at the end of each calendar month thereafter."}],"balance_after":30000,"derivative":{"exercise_price":63.43,"expiration_date":"2031-03-25","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001217234-21-000059","document":"wf-form4_161670936613832.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723421000059/wf-form4_161670936613832.xml","form_type":"4"}},{"id":2771754,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":62092,"kind":"person","name":"Dhingra Ankur","position":1,"cik":"0001849682","reported_name":"Dhingra Ankur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-25T21:56:23.000Z","date":"2021-03-25","kind":"grant","acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units, 1/4th of which shall vest on March 25, 2022 and 1/4th of which shall vest on each anniversary thereafter."}],"balance_after":14500,"source":{"system":"sec-edgar","filing":"0001217234-21-000059","document":"wf-form4_161670936613832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723421000059/wf-form4_161670936613832.xml","form_type":"4"}}]}